18 matches.
- Life Sciences Investor Services
Represented Growth Investment Firm in $150 Million Acquisition of Integrated Research Partner - Health Care Mergers and Acquisitions
Advised on Acquisition of Clinical Research Assets - Mergers, Acquisitions & Divestitures
Advised Private Equity Firm in Acquisition of Specialty Pharmacy Services Provider - Dietary Supplement Litigation
Represented Start-Up in Fraudulent Inducement and Unfair Competition Lawsuit - Health Care Mergers and Acquisitions
Advised Private Equity Sponsors in Acquisition of Medical Equipment Manufacturer - Life Sciences Investor Services
Represented Venture Capital in Strategic Investment in Biotechnology Company - Health Care Investor Services
Health Regulatory Due Diligence for Private Equity - Life Sciences Investor Services
Due Diligence in Acquisition of Non-Prescription Drug and Personal Care Manufacturer - Life Sciences Investor Services
Regulatory Counsel and Due Diligence Review Results in Successful Merger - Return to Work
Advised on COVID-19 Return to Work for Pharmaceutical Manufacturer - Privacy Compliance Strategies
Advised Multimedia and E-commerce Marketing Company on Privacy Compliance for Promotional Activities - Drug and Medical Device Distribution
Regulatory and Compliance Considerations for Medical Device Manufacturer - Health Care Investor Services
Regulatory Counsel for Private Equity Firm in Multibillion-Dollar Acquisition - Pharmaceuticals
Represented Pharmaceutical Manufacturer in Product Development and Supply Arrangements - Life Sciences Investor Services
Represented Private Equity in Strategic Acquisition of Drug Contract Manufacturing Business - Pharmaceuticals
Promotional Material Review for Pharmaceutical Company - Life Sciences Investor Services
Private Equity Due Diligence for Acquisition of Medical Device Manufacturer - Mergers, Acquisitions & Divestitures
Epstein Becker Green Successfully Assists Client in $2.6 Billion Acquisition